β-2-Microglobulin and Main Granulocyte Components in Hemodialysis Patients
- 1 April 1989
- journal article
- research article
- Published by Wiley in Artificial Organs
- Vol. 13 (2) , 92-96
- https://doi.org/10.1111/j.1525-1594.1989.tb02842.x
Abstract
Plasma levels of granulocyte elastase in complex with .alpha.1-proteinase inhibitor (E-.alpha.1-PI) increased during hemodialysis from 110 .+-. 10 to 506 .+-. 66 .mu.g/L using dialyzers made of polyamide, from 95 .+-. 2.2 to 211 .+-. 54 .mu.g/ml with hemophane and from 114 .+-. 10 to 203 .+-. 25 using dialyzers made of polysulfone. Plasma lactoferrin values were also significantly higher during hemodialysis with polyamide (772 .+-. 110 .mu.g/L) compared with hemophane (268 .+-. 2.2) and the polysulfone (278 .+-. 31 .mu.g/L) dialyzer. After dialysis each dialyzer was rinsed. We found the lowest concentration of lactoferrin (90.2 .+-. 254 .mu.g/L) and E-.alpha.1-PI (739 .+-. 162 .mu.g/L) after rinsing polysulfone dialyzers, whereas the highest concentrations were observed after rinsing the polyamide dialyzers (lactoferrin: 2,426 .+-. 314; E-.alpha.1-PI: 1,134 .+-. 144 .mu.g/L). Hemodialysis with polysulfone dialyzers caused significantly lower plasma levels of .beta.-2-microglobulin compared with polyamide or hemophane membranes despite significantly lower levels in the rinsing solutions. Our data indicate that low plasma levels of main granulocyte component observed with polysulfone and hemophane dialyzers are not the result of higher membrane adsorption of E-.alpha.1-PI and lactoferrin. These main granulocyte components are not related to .beta.-2-microglobulin levels of both plasma and rinsing solutions.Keywords
This publication has 20 references indexed in Scilit:
- Granulocyte activation during haemodialysis in the absence of complement activation: inhibition by calcium channel blockersEuropean Journal of Clinical Investigation, 1988
- Deposition of Terminal C5b–9 Complement Complexes on Erythrocytes and Leukocytes during Cardiopulmonary BypassNew England Journal of Medicine, 1988
- Characterization of non-TCA-precipitable ‘Lowry protein’ in plasma of patients with acute renal failureClinica Chimica Acta; International Journal of Clinical Chemistry, 1987
- Serum Levels of β2-Microglobulin as a New Form of Amyloid Protein in Patients Undergoing Long-Term HemodialysisNew England Journal of Medicine, 1986
- Plasma levels of granulocyte elastase during hemodialysis: Effects of different dialyzer membranesKidney International, 1985
- Complement Activation During Hemodialysis: Clinical Observations, Proposed Mechanisms, and Theoretical ImplicationsArtificial Organs, 1984
- Enzyme-Linked Immunoassay for Human Granulocyte Elastase in Complex with α1 -Proteinase InhibitorPublished by Springer Nature ,1984
- Anaphylatoxin formation during hemodialysis: Effects of different dialyzer membranesKidney International, 1983
- Release of Granulocyte Proteinases during HemodialysisAmerican Journal of Nephrology, 1983
- Complement Activation during Cardiopulmonary BypassNew England Journal of Medicine, 1981